Head and Neck Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Head and Neck Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer [Phase 2]
This document reports the completion of a Phase II trial evaluating the efficacy and safety of P276-00 in recurrent and/or locally advanced …
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck [Phase 1]
This Phase 1 trial evaluating a combination of sunitinib, cetuximab, and radiation therapy in locally advanced or recurrent head and neck sq…
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors [Phase 2]
Phase 2 trial update of TPF followed by cetuximab and IMRT with a carbon ion boost for locally advanced head and neck squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating cisplatin plus gemcitabine in patients with advanced squamou…
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 2]
Phase 2 trial assessing whether adding erlotinib to cisplatin-based radiation improves outcomes in stage III/IV head and neck squamous cell …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer [Phase 2]
Results from a Phase 2 trial for recurrent or metastatic head and neck squamous cell carcinoma sponsored by Eli Lilly; trial has completed a…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck [Phase 2]
Phase 2 trial update evaluating ixabepilone in patients with metastatic or recurrent head and neck squamous cell carcinoma; the study has co…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]
Clinical trial updates show Erlotinib tested in patients with advanced Non-small Cell Lung Cancer, Ovarian Epithelial Cancer, and Head and N…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery [Phase 1, Phase 2]
This document reports on a completed Phase 1/2 trial evaluating neoadjuvant cetuximab followed by curative surgery in head and neck squamous…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery [Phase 1, Phase 2]
A completed Phase 1/2 trial profiling plasma growth factors before and after head and neck surgery in patients with head and neck squamous c…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck [Phase 1]
A Phase 1 study evaluating MRX with radiation and chemotherapy for patients with resected head and neck squamous cell carcinoma was terminat…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects [Phase 3]
This Phase 3 trial update reports the results of adding cetuximab to radiotherapy for locally advanced head and neck squamous cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck [Phase 3]
Phase 3 trial evaluating safety and anti-tumor activity of cetuximab in combination with cisplatin and 5-fluorouracil in recurrent and/or me…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer [Phase 1]
A Phase 1 clinical trial update reports completion of a study evaluating cetuximab in combination with everolimus for patients with metastat…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation [NA]
This completed clinical trial from Stanford evaluates the correlation between MRI, FDG-PET imaging, and histopathology for cervical nodal me…
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC)
A DAHANCA trial update evaluating the prognostic value of the PET tracer 18F-FAZA in head and neck squamous cell carcinoma (HNSCC).
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 1]
A Phase 1 study evaluating erlotinib and docetaxel with concomitant boost radiation therapy for head and neck squamous cell carcinoma has co…
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 2]
Phase 2 trial evaluating induction chemotherapy with nimotuzumab in locally advanced head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-23Clinical Trial Update: Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 trial of zalutumumab in combination with chemotherapy and radiotherapy for head and neck squamous cell carcinoma was terminated; r…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC [Phase 3]
Phase 3 trial assessing accelerated radiotherapy with concomitant chemoradiotherapy for head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-23Clinical Trial Update: Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer [Phase 1]
A Phase 1 study of pemetrexed (Alimta) in patients with head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Imatinib Mesylate (Gleevec) and Docetaxel in patients with head and neck squamous cell …
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 2]
Phase 2 trial evaluating the combination of docetaxel and S-1 in head and neck squamous cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating metronomic tegafur/uracil chemotherapy for head and neck squamous cell carcinoma. The current statu…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) [Phase 2]
Phase 2 study evaluating cetuximab plus concomitant-boost radiotherapy in newly diagnosed locally advanced head and neck squamous cell carci…